Medical Xpress·3 min read·medium
Newer obesity drugs linked to fewer alcohol-related hospitalizations for people with alcohol dependence
B
British Medical Journal
✦AI Summary
A study published in BMJ Open indicates that GLP-1 receptor agonists like semaglutide and tirzepatide are associated with a significant reduction in alcohol-related hospitalizations. The research suggests these obesity and diabetes medications may have therapeutic potential for treating alcohol use disorder.
edited by Sadie Harley , reviewed by Andrew Zinin
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in